Edition:
United States

ICU Medical Inc (ICUI.OQ)

ICUI.OQ on NASDAQ Stock Exchange Global Select Market

220.45USD
15 Dec 2017
Change (% chg)

-- (--)
Prev Close
$220.45
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
45,240
52-wk High
$220.95
52-wk Low
$127.00

Summary

Name Age Since Current Position

Vivek Jain

57 2014 Chairman of the Board, Chief Executive Officer

Scott Lamb

54 2008 Chief Financial Officer, Treasurer

Alison Burcar

44 2017 Corporate Vice President, General Manager - Infusion Consumables

Tom McCall

59 2017 Corporate Vice President - Marketing and Communications, General Manager - Critical Care

Steven Riggs

58 2017 Corporate Vice President - Operations

Elisha Finney

55 2016 Independent Director

Douglas Giordano

53 2017 Independent Director

David Greenberg

50 2015 Independent Director

Joseph Saucedo

74 2001 Independent Director

Robert Swinney

71 1998 Independent Director

John Mills

2016 IR Contact Officer

Biographies

Name Description

Vivek Jain

Mr. Vivek Jain is Chairman of the Board and Chief Executive Officer of the Company. Mr. Jain served as CareFusion Corporation's ("CareFusion") President of Procedural Solutions from 2011 to February 2014. Mr. Jain served as President, Medical Technologies and Services of CareFusion from 2009 until 2011. Mr. Jain served as the Executive Vice-President-Strategy and Corporate Development of Cardinal Health from 2007 until 2009. Mr. Jain served as Senior Vice President, Business Development and M&A for the Philips Medical Systems business of Koninklijke Philips Electronics N.V. an electronics company from 2006 to August 2007. Mr. Jain served as an investment banker at J.P. Morgan Securities, Inc. an investment banking firm, from 1994 to 2006. Mr. Jain's last position with J.P. Morgan was as Co-Head of Global Healthcare Investment Banking from 2002 to 2006.

Scott Lamb

Mr. Scott E. Lamb is Chief Financial Officer, Treasurer of the Company. Mr. Lamb served as our Controller from 2003 to February 2008. Mr. Lamb served as Senior Director of Finance for Vitalcom, Inc. from 2000 to 2003.

Alison Burcar

Ms. Alison D. Burcar is Corporate Vice President, General Manager - Infusion Consumables of the Company. Ms. Burcar served as our Vice President and General Manager of Infusion Systems from July 2014 to February 2017. Ms. Burcar served as Vice President of Product Development from July 2009 to July 2014. Ms. Burcar served as our Vice President of Marketing from 2002 to July 2009, our Marketing Operations Manager from 1998 to 2002 and held research and development project/program management positions from 1995 to 1998.

Tom McCall

Mr. Tom McCall is Corporate Vice President - Marketing and Communications ,General Manager - Critical Care of the Company. Mr. McCall served as our Vice President and General Manager of Critical Care from July 2014 to February 2017. Mr. McCall served as our Vice President of Marketing from July 2010 to July 2014. Mr. McCall served as Vice President of Marketing Communications and Brand Strategy for Masimo Corporation from 2006 to 2010 and as Vice President of Corporate Marketing and Brand Development for Welch Allyn, Inc. from 2001 to 2006.

Steven Riggs

Mr. Steven C. Riggs is Vice President - Operations of the Company. Mr. Riggs served as our of Vice President of Operations from 2002 to October 2013 and resumed this position in February 2014 and served until February 2017. Mr. Riggs served as Acting Chief Executive Officer from October 2013 to February 2014. Mr. Riggs served as our Director of Operations from 1998 to 2002 and as our Senior Manager of Quality Assurance and Quality Control from 1992 to 1998.

Elisha Finney

Ms. Elisha W. Finney is Independent Director of ICU Medical, Inc. Ms Finney was named Vice President, Finance and CFO of Varian Medical Systems in April 1999. In January 2005, she was promoted to Senior Vice President and given additional management responsibility for the Corporate Information Systems group. She was named Executive Vice President in February 2012. Varian Medical Systems is a leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. Today, Ms. Finney manages a worldwide staff of 400. Her management responsibilities include corporate accounting; corporate communications and investor relations; internal financial and compliance audit; risk management; tax and treasury, and corporate information systems. Ms. Finney joined Varian as risk manager in 1988 and has assumed a wide variety of finance functions over her last 27 years with the company. Prior to joining Varian, Ms. Finney was with the Fox Group in Foster City, CA, and Beatrice Foods, a major food processing company, in Chicago, IL. Ms. Finney has served on the board of iRobot Corporation, a robotics technology company, since January 2017. Ms. Finney previously served on the boards of directors of: Laserscope from August 2005 until July 2006 when Laserscope was sold to American Medical Systems; Thoratec, a developer, manufacturer and marketer of proprietary medical devices for mechanical circulatory support from July 2007 to May 2013; and Altera Corporation, a manufacturer of programmable logic devices from September 2011 until December 2015, when Altera was sold to Intel.

Douglas Giordano

Mr. Douglas E. Giordano serves as Independent Director of the company. Mr. Giordano is responsible for Pfizer’s mergers and acquisitions, licensing and partnering activities. Mr. Giordano has had a series of strategy, business development and operating roles at Pfizer. He has been a key contributor to a variety of Pfizer transactions - including Pfizer’s acquisition and integration of Wyeth, Hospira, Medivation, and Anacor and the partnerships with Merck KGa, Eli Lilly, and BMS. Mr. Giordano also lead a variety of innovative US commercialization initiatives including the creation and launch of the Pfizer/Microsoft/IBM collaboration, Amicore, and the launch of the Pfizer for Living ShareCard and Pfizer Helpful Answers programs. Earlier in his Pfizer career Mr. Giordano worked in a mergers and acquisitions role within Pfizer’s Medical Technology Group - playing a key role in Pfizer’s acquisitions, technology licensing, and divestiture activity within medtech. Mr. Giordano is a director at ViiV Healthcare Limited, a private pharmaceutical company that develops HIV therapies and served as a director at Zoetis Inc. the world's largest producer of medicine and vaccinations for pets and livestock, from July 2012 to June 2013.

David Greenberg

Mr. David C. Greenberg is the Independent Director of the Company. He has been Executive Vice President, Strategy of Medline Industries, Inc. (“Medline”) since June, 2008. In that capacity, Mr. Greenberg is a member of Medline’s Executive Board and advises top leadership/ownership on all aspects of the business. Mr. Greenberg is responsible for Strategy, Business Development and M&A. Additionally, Mr. Greenberg is a Group President and has responsibility for Medline’s distribution business and several manufacturing and marketing divisions. Previously, Mr. Greenberg spent thirteen years in a variety of leadership positions within Aon Corporation, including Chief Financial Officer of its Aon Global subsidiary. Mr. Greenberg serves on the Board of Directors for Amendia, Inc. a spinal implant company. The Board of Directors benefits from Mr. Greenberg's extensive knowledge and experience in the medical industry, his demonstrated extensive leadership in business and his insight into financial matters. The Board of Directors has determined that Mr. Greenberg is an "audit committee financial expert" and is "independent," as those terms are defined by applicable Nasdaq Listing Rules and SEC regulations.

Joseph Saucedo

Mr. Joseph R. Saucedo is an Independent Director of ICU Medical Inc. He is Chairman and President of Bolsa Resources, Inc. a business management consulting firm that provides both management consulting and financial accounting function support to manufacturing companies. He has a Masters in Business Administration. Mr. Saucedo’s 30 years of financial and accounting experience include serving as President and CEO of a financial institution where he was responsible for overseeing the performance of the company, as an auditor for a major auditing firm, and currently, the review, analysis and evaluation of clients’ financial statements and financial consulting to manufacturing concerns. The Board of Directors is well served by having Mr. Saucedo on the Board of Directors in part because it believes that his financial knowledge and experience is valuable to the Board of Directors, particularly with respect to his service on the Audit Committee. Additionally, his wide range of experiences from the CEO of a financial institution to an auditor at a major auditing firm provide him with insight into all financial aspects of a company. The Board of Directors has determined that Mr. Saucedo is an “audit committee financial expert” and is “independent,” as those terms are defined by applicable Nasdaq Listing Rules and SEC regulations.

Robert Swinney

Dr. Robert S. Swinney, M.D. is an Independent Director of ICU Medical Inc. Previously, he served as a director from 1989 to October 1995. Dr. Swinney has more than 30 years of experience as a critical care physician in a large, public teaching hospital, where he has formerly served as the critical care unit director and Chair of the ICU Committee. Dr. Swinney also has experience in private primary care practice and emergency medicine. He holds two patents for medical products and, in his daily work, is frequently called upon to examine and evaluate new medical products. The Board benefits from Dr. Swinney’s medical and leadership experience, including Dr. Swinney’s work with patents, as well as his ongoing work, which has provided him with a high level of technical expertise, which keep him current on new developments in medical technology.

John Mills

Basic Compensation

Name Fiscal Year Total

Vivek Jain

3,551,850

Scott Lamb

1,222,410

Alison Burcar

1,214,640

Tom McCall

887,332

Steven Riggs

1,116,430

Elisha Finney

285,225

Douglas Giordano

--

David Greenberg

210,176

Joseph Saucedo

235,176

Robert Swinney

230,176

John Mills

--
As Of  30 Dec 2016